Funded Grants

PI Name	PI Organization	Title	Grant Number	Program Official Sort descending
Altorki, Nasser Khaled	Weill Medical Coll Of Cornell Univ United States	Intercepting progression from pre-invasive to invasive lung adenocarcinoma	3UH3CA244697-05S1	Mark Steven Miller, Ph.D.
Altorki, Nasser Khaled	Weill Medical Coll Of Cornell Univ United States	Intercepting progression from pre-invasive to invasive lung adenocarcinoma	3UH3CA244697-05S1	Mark Steven Miller, Ph.D.
Altorki, Nasser Khaled	Weill Medical Coll Of Cornell Univ United States	Intercepting progression from pre-invasive to invasive lung adenocarcinoma	3UH3CA244697-05S1	Mark Steven Miller, Ph.D.
Lipkin, Steven M	Weill Medical Coll Of Cornell Univ United States	Neoantigen Vaccination for Lynch Syndrome Immunoprevention	5U01CA233056-05	Mark Steven Miller, Ph.D.
Largaespada, David Andrew	University Of Minnesota United States	Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention	5UH3CA244687-05	Mark Steven Miller, Ph.D.
Altorki, Nasser Khaled	Weill Medical Coll Of Cornell Univ United States	Intercepting progression from pre-invasive to invasive lung adenocarcinoma	3UH3CA244697-05S1	Mark Steven Miller, Ph.D.
Nathan, Cherie-Ann O	Louisiana State Univ Hsc Shreveport United States	Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.	5R01CA217180-05	Howard L. Parnes, M.D.
Kim, Hyung L	Cedars-Sinai Medical Center United States	Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer	1R01CA280060-01A1	Howard L. Parnes, M.D.
Tangen, Catherine M.	Fred Hutchinson Cancer Center United States	PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research	5U01CA182883-11	Howard L. Parnes, M.D.
Hansen, Laura A	Creighton University United States	Targeting aberrant anti-apoptotic signaling for prevention of skin cancer	5R01CA253573-05	Howard L. Parnes, M.D.